Abstract:Background: Ubiquitin-conjugating enzyme 2T (UBE2T) has been reported to be associated with uncontrolled cell growth and tumorigenesis in multiple cancer types. However, the understanding of its regulatory role in the carcinogenesis of Head And Neck Squamous Cell Carcinoma (HNSC) is limited. background: Ubiquitin-conjugating enzyme 2T (UBE2T) has been associated with uncontrolled cell growth and tumorigenesis in multiple cancer types. Methods: UBE2T expression in HNSC patient samples and the correlation between its expression and patients’ survival rates were evaluated using The Cancer Genome Atlas (TCGA) database. Cell survival and proliferation were investigated in UM-SCC1 and UM-SCC15 cells infected with control and shUBE2T lentivirus. The xenograft mouse model was established using UM-SCC15 cells to examine HNSC tumorigenesis with or without UBE2T. Western blot, qRT-PCR, and ferroptosis assays were carried out to disclose the interaction between UBE2T and NF-κB signaling and ferroptosis. objective: To study the understanding of its regulatory role in the carcinogenesis of head and neck squamous cell carcinoma (HNSC). Results: The increased expression of UBE2T was noted in tumor tissues of patients with HNSC, correlating with a significantly reduced overall survival time in this patient cohort. Knockdown of UBE2T inhibited HNSC tumorigenesis and tumor growth. Mechanistically, inhibition of UBE2T suppressed NF-κB signaling and induced ferroptosis in HNSC. method: UBE2T expression in HNSC patient samples and the correlation between its expression and patients’ survival rates were evaluated using TCGA database. Cell survival and proliferation were investigated in UM-SCC1 and UM-SCC15 cells infected with control and shUBE2T-derived lentivirus. Cell line-derived xenograft mouse model was established using UM-SCC15 cells to examine HNSC tumorigenesis with or without UBE2T. Western blot, qRT-PCR, and ferroptosis assays were carried out to disclose the interaction between UBE2T and NF-κB signaling and ferroptosis. Conclusion: Our study underscores the multifaceted role of UBE2T in HNSC, illuminating its potential as a biomarker and therapeutic target. result: High expression of UBE2T were consistently observed in HNSC tumor tissues, which correlated with a significantly shortened overall survival time among HNSC patients. Knockdown of UBE2T inhibited HNSC tumorigenesis and tumor growth. Mechanistically, inhibition of UBE2T suppressed NF-κB signaling activation and induced ferroptosis in HNSC.

SET protein accumulation prevents cell death in head and neck squamous cell carcinoma through regulation of redox state and autophagy

Cyclin-dependent Kinase 1-Mediated Phosphorylation of SET at Serine 7 is Essential for Its Oncogenic Activity

Reprogramming the oncogenic response: SET protein as a potential therapeutic target in cancer

SETD4 Confers Cancer Stem Cell Chemoresistance in Nonsmall Cell Lung Cancer Patients Via the Epigenetic Regulation of Cellular Quiescence

Tumor cell-intrinsic SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway

Integrated Genomic and Proteomic Analyses Reveal Novel Mechanisms of the Methyltransferase SETD2 in Renal Cell Carcinoma Development.

Inhibition of Pten deficient Castration Resistant Prostate Cancer by Targeting of the SET - PP2A Signaling axis

SET Protein Overexpression Contributes to Paclitaxel Resistance in MCF-7/S Cells Through PI3K/Akt Pathway

Selenomethionine suppresses head and neck squamous cell carcinoma progression through TopBP1/ATR and TCAB1 signaling

Silencing of SETD6 inhibits the tumorigenesis of oral squamous cell carcinoma by inhibiting methylation of PAK4 and RelA

Involvement of Set in the Wnt Signaling Pathway and the Development of Human Colorectal Cancer

Deficiency of Histone H3K36 Methyltransferase SETD2 Inhibits Proliferation and Migration of Hepatocellular Carcinoma Through ERK Pathway

Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma

Downregulation of the Histone Methyltransferase SETD2 Promotes Imatinib Resistance in Chronic Myeloid Leukaemia Cells

APC coordinates GSK3 phosphorylation of SETD8 to suppress colorectal cancer

Abstract PR07: SETD1B mutations confer apoptosis resistance and BCL2 independence in B-cell lymphoma

Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma

SETDB1 Modulates Degradation of Phosphorylated RB and Anticancer Efficacy of CDK4/6 Inhibitors

A Comprehensive and Perspective View of Oncoprotein SET in Cancer

Knockdown of Ubiquitin-Conjugating Enzyme E2 T Abolishes the Progression of Head and Neck Squamous Cell Carcinoma by Inhibiting NF-Κb Signaling and inducing Ferroptosis

Downregulation of SELENBP1 Enhances Oral Squamous Cell Carcinoma Chemoresistance Through KEAP1–NRF2 Signaling